Hälsa & medicin
3.9
Major diabetes conference reveals fresh data on heart, kidney protection
New research presented at the 2022 CVOT Summit identifies improved outcomes for diabetic patients across cardiovascular, kidney, and blood-sugar metrics. The findings could reshape treatment protocols and influence pharmaceutical development priorities for companies targeting the $100+ billion diabetes care market.
Originaltitel: CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes